|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 10 (May 15), 1999:
pp. 3401-3407
Ongoing Prothrombotic State in Patients With Antiphospholipid
Antibodies: A Role for Increased Lipid Peroxidation
Domenico Praticò,
Domenico Ferro,
Luigi Iuliano,
Joshua Rokach,
Fabrizio Conti,
Guido Valesini,
Garret A. FitzGerald, and
Francesco Violi
From the Institute of Clinical Medicine I, University "La
Sapienza," Rome, Italy; and the Center for Experimental
Therapeutics, University of Pennsylvania, Philadelphia, PA.
We measured the urinary excretion of Isoprostane
F2 -III and Isoprostane-F2-VI, two markers
of in vivo lipid peroxidation, and the circulating levels of the
prothrombin fragment F1+2, a marker of thrombin generation, in 18 antiphospholipid antibodies-positive patients, in 18 antiphospholipid
antibodies-negative patients with systemic lupus erythematosus, and in
20 healthy subjects. Furthermore, 12 patients positive for
antiphospholipid antibodies were treated with (n = 7) or without (n
= 5) antioxidant vitamins (vitamin E at 900 IU/d and vitamin C at
2,000 mg/d) for 4 weeks. Compared with antiphospholipid
antibodies-negative patients, antiphospholipid antibodies-positive
patients had higher urinary values of Isoprostane-F2-III
(P = .0001), Isoprostane-F2-VI (P = .006), and plasma levels of the prothrombin fragment F1+2 (P
= .0001). In antiphospholipid-positive patients, F1+2 significantly correlated with Isoprostane-F2-III (Rho = .56, P = .017) and Isoprostane-F2-VI (Rho
= .61, P = .008). After 4 weeks of supplementation with
antioxidant vitamins, we found a significant decrease in F1+2 levels
(P < .005) concomitantly with a significant reduction of both
Isoprostane-F2-III (P = .007) and
Isoprostane-F2-VI (P < .005). No change of these variables was observed in patients not receiving antioxidant treatment. This study suggests that lipid peroxidation might contribute to the activation of clotting system in patients positive for antiphospholipid antibodies.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E Matsuura, K Kobayashi, B. Hurley, and L. Lopez
Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Lupus,
July 1, 2006;
15(7):
478 - 483.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Buttari, E. Profumo, V. Mattei, A. Siracusano, E. Ortona, P. Margutti, B. Salvati, M. Sorice, and R. Rigano
Oxidized {beta}2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response
Blood,
December 1, 2005;
106(12):
3880 - 3887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Davi and A Falco
Oxidant stress, inflammation and atherogenesis
Lupus,
September 1, 2005;
14(9):
760 - 764.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Safa, C. T. Esmon, and N. L. Esmon
Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-{beta}2-glycoprotein I monoclonal antibodies
Blood,
September 1, 2005;
106(5):
1629 - 1635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Simoncini, C. Sapet, L. Camoin-Jau, N. Bardin, J.-R. Harle, J. Sampol, F. Dignat-George, and F. Anfosso
Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome
Int. Immunol.,
April 1, 2005;
17(4):
489 - 500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Sanguigni, D. Ferro, P. Pignatelli, M. Del Ben, T. Nadia, M. Saliola, R. Sorge, and F. Violi
CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia
J. Am. Coll. Cardiol.,
January 4, 2005;
45(1):
35 - 42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wurzel, B. I. Goldman, A. Doria, Y. Shoenfeld, P. Pauletto, F. Violi, L. Loffredo, D. Ferro, F. Pezzetta, L. Mascitelli, et al.
Premature Coronary Disease in Systemic Lupus
N. Engl. J. Med.,
April 8, 2004;
350(15):
1571 - 1575.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E Upritchard, C. R. Schuurman, A. Wiersma, L. B. Tijburg, S. A. Coolen, P. J Rijken, and S. A Wiseman
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
Am. J. Clinical Nutrition,
November 1, 2003;
78(5):
985 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Griendling and G. A. FitzGerald
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Circulation,
October 28, 2003;
108(17):
2034 - 2040.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schattner and M. H. Liang
The Cardiovascular Burden of Lupus: A Complex Challenge
Arch Intern Med,
July 14, 2003;
163(13):
1507 - 1510.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Hodgson, K. D. Croft, T. A. Mori, V. Burke, L. J. Beilin, and I. B. Puddey
Regular Ingestion of Tea Does Not Inhibit In Vivo Lipid Peroxidation in Humans
J. Nutr.,
January 1, 2002;
132(1):
55 - 58.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Heinecke
Is the Emperor Wearing Clothes?: Clinical Trials of Vitamin E and the LDL Oxidation Hypothesis
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2001;
21(8):
1261 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald
Effects of Vitamin E on Lipid Peroxidation in Healthy Persons
JAMA,
March 7, 2001;
285(9):
1178 - 1182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Horkko, T. Olee, L. Mo, D. W. Branch, V. L. Woods Jr, W. Palinski, P. P. Chen, and J. L. Witztum
Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both {beta}2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein
Circulation,
February 20, 2001;
103(7):
941 - 946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Pratico, R. K. Tangirala, S. Horkko, J. L. Witztum, W. Palinski, and G. A. FitzGerald
Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2{alpha}-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E
Blood,
January 15, 2001;
97(2):
459 - 464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P R J Ames, C Tommasino, J Alves, J D Morrow, L Iannaccone, G Fossati, S Caruso, F Caccavo, and V Brancaccio
Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study
Lupus,
November 1, 2000;
9(9):
688 - 695.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Safa, K. Hensley, M. D. Smirnov, C. T. Esmon, and N. L. Esmon
Lipid Oxidation Enhances the Function of Activated Protein C
J. Biol. Chem.,
January 12, 2001;
276(3):
1829 - 1836.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
